Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: reversal by glatiramer acetate
- PMID: 16083971
- DOI: 10.1016/j.jneuroim.2005.07.001
Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: reversal by glatiramer acetate
Abstract
Neuronal growth factors may exert a neuroprotective effect in multiple sclerosis (MS). We found reduced levels of brain-derived neurotrophic factors (BDNF) in the serum and CSF of relapsing-remitting MS patients, which was reversed by therapy with glatiramer acetate. BDNF may play a protective role in MS, and immunomodulation therapy, such as with glatiramer acetate, may enhance the action this mechanism.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources